First Day of Dealings

RNS Number : 1052Q
Phoenix Spree Deutschland Limited
15 June 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA, OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

15 June 2015

Phoenix Spree Deutschland Limited

First Day of Dealings

Phoenix Spree Deutschland Limited (the "Company") is pleased to announce the admission of the Company's ordinary shares (the "Shares") to the premium listing segment of the Official List of the Financial Conduct Authority and the commencement of dealings on the London Stock Exchange plc's Main Market for listed securities at 8.00 am today ("Admission").

The total number of ordinary shares in the Company in issue immediately following Admission is 69,872,298 each with equal voting rights.  This total voting rights figure can be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in the Company under the Disclosure and Transparency Rules of the Financial Conduct Authority.

The Shares will trade under the TIDM PSDL (ISIN: JE00B248KJ21).

ENQUIRIES

For further information, please contact:

PMM Partners (Property Advisor)                                                                     
Mike Hilton

Matthew Northover

Paul Ruddle

Stuart Young

 

+44 (0)20 8973 1020

Liberum (Sponsor)                                                                                           
Richard Crawley

Christopher Britton

 

+44 (0)20 3100 2222

Bell Pottinger (Financial Public Relations)

Victoria Geoghegan

Jo Boon

Nick Lambert

 

+44 (0)20 3772 2500

 

IMPORTANT INFORMATION

This announcement does not constitute or form part of, and should not be construed as, an offer to sell or issue, or a solicitation of any offer to buy or subscribe for, any securities, nor shall it or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or commitment whatsoever. This announcement does not constitute a recommendation regarding any securities. Investors should not subscribe for or purchase any securities referred to in this announcement except on the basis of information in the prospectus published by the Company on 10 June 2015, and any supplement thereto.

 

Liberum, which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and for no-one else in connection with Admission and the arrangements referred to in this announcement and is not acting for nor will it be responsible to any other person in connection with Admission including for providing the protections afforded to clients of Liberum or for providing advice in connection with Admission, the contents of this announcement or any matters referred to in this announcement. Liberum is not responsible for the contents of this announcement. Liberum has not authorised the contents of, or any part of, this announcement and no liability whatsoever is accepted by Liberum nor does it make any representation or warranty, express or implied, for the accuracy of any information or opinion contained in this announcement or for the omission of any information. Liberum disclaims all and any responsibility or liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement. This does not exclude or limit any responsibilities which Liberum may have under FSMA or the regulatory regime established thereunder.

 

The distribution of this announcement and other documents and/or information in connection with the Admission in other jurisdictions may be restricted by law and therefore neither this announcement nor any other documents and/or information in connection with Admission may be published, distributed or transmitted by any means or media directly or indirectly, in whole or in parts in or into any jurisdiction except under circumstances that will result in compliance with any applicable laws and regulations. Persons into whose possession any document and/or other information referred to herein comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdictions. This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction in which such offer would be unlawful. In particular, this announcement does not constitute an offer to buy securities, and it is not for distribution, directly or indirectly, in or into the United States of America, Canada, Australia, the Republic of South Africa, or Japan.

 

The Shares have not been, and will not be, registered under the United States Securities Act 1933 (as amended) nor under the securities laws or with any securities regulatory authority of any state or other jurisdiction of the United States of America or of any province or territory of Canada, Australia, the Republic of South Africa or Japan, nor in any country or territory where to do so may contravene local securities laws or regulations and will not be made to any national, resident or citizen of the United States of America, Canada, Australia, the Republic of South Africa or Japan. In addition, the Company has not been, and will not be, registered under the United States Investment Company 1940 (as amended).

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSRRRVOANAUR
UK 100

Latest directors dealings